Ken Griffin Integer Holdings Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$110.25 - $131.62 $66,150 - $78,972	600 Added 9.23%	7,100 $923,000
Q2 2024 Aug 14, 2024	SELL	$109.58 - $123.27 $646,522 - $727,293	-5,900 Reduced 47.58%	6,500 $752,000
Q1 2024 May 15, 2024	BUY	$96.48 - $116.68 $250,848 - $303,368	2,600 Added 26.53%	12,400 $1.45 Million
Q4 2023 Feb 14, 2024	SELL	$69.42 - $100.2 $423,462 - $611,220	-6,100 Reduced 38.36%	9,800 $970,000
Q3 2023 Nov 14, 2023	BUY	$78.43 - $93.24 $533,324 - $634,032	6,800 Added 74.73%	15,900 $1.25 Million
Q2 2023 Aug 14, 2023	SELL	$75.44 - $88.64 $143,336 - $168,416	-1,900 Reduced 17.27%	9,100 $806,000
Q1 2023 May 15, 2023	SELL	$65.81 - $78.67 $98,715 - $118,005	-1,500 Reduced 12.0%	11,000 $852,000
Q4 2022 Feb 14, 2023	SELL	$51.11 - $74.32 $127,775 - $185,799	-2,500 Reduced 16.67%	12,500 $855,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $76.22 $5,950 - $7,622	100 Added 0.67%	15,000 $933,000

355

38.5M

13.7K

8.1K

Ticker ITGR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,131,000
Market Cap $4.43B
Description
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional o...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.